Aptorum Group (Aptorum Group) Market Cap : $26.70 Mil (As of Apr. 29, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aptorum Group's share price for the quarter that ended in Jun. 2023 was $2.7. Aptorum Group's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 5.18 Mil. Therefore, Aptorum Group's market cap for the quarter that ended in Jun. 2023 was $13.99 Mil.

Aptorum Group's quarterly market cap declined from Jun. 2022 ($48.91 Mil) to Dec. 2022 ($19.64 Mil) and declined from Dec. 2022 ($19.64 Mil) to Jun. 2023 ($13.99 Mil).

Aptorum Group's annual market cap declined from Dec. 2020 ($84.03 Mil) to Dec. 2021 ($53.46 Mil) and declined from Dec. 2021 ($53.46 Mil) to Dec. 2022 ($19.64 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aptorum Group's Enterprise Value for Today is $29.05 Mil.

Aptorum Group Market Cap Historical Data

The historical data trend for Aptorum Group's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Market Cap Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

Get a 7-Day Free Trial

439.84

460.20

84.03

53.46

19.64

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Market Cap	Get a 7-Day Free Trial							113.77	53.46	48.91	19.64	13.99

Competitive Comparison of Aptorum Group's Market Cap

For the Biotechnology subindustry, Aptorum Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptorum Group's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's Market Cap distribution charts can be found below:

* The bar in red indicates where Aptorum Group's Market Cap falls into.

Aptorum Group Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Aptorum Group's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$5.501	*	3.57073
	=	$19.64

Aptorum Group's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	$2.7	*	5.1817
	=	$13.99

Aptorum Group (NAS:APM) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Aptorum Group Market Cap Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.